During Amanda's hospitalization I had purchased my first copy of Maye's Midwifery. I expected it to re-state American nursing texts. It was here that my assumptions regarding breast feeding as protective against vitamin K deficiency were challenged. In fact, I closed the book and decided I did not like what I read. Maye's was stating exactly the opposite of what I believed. Until this time I was sure bottle fed infants were more at risk due to the sterile nature of formula, especially since my parents had a difficult time getting oral vitamin K prescriptions filled by their physicians. They were told that oral vitamin K preparations didn't work. So why would vitamin K fortification in formula work any better? In addition my personal bias that breast feeding offers optimal nutrition for infants and could not possibly be associated as a risk factor for any disease allowed me to continue along the line of thought that there was a natural protection with breast feeding. I believed that vitamin K deficiency was a genetic problem. After all the human body has survived well during birth and breast feeding since humans have walked this Earth. There are plenty of home born babies who have been exclusively breast fed, did not receive vitamin K, and did not have a deficiency. What makes one infant at risk, and another not if isn't genetic? Again, vitamin K administration is a new phenomenon in the relative history of mankind. Researchers are still attempting to decipher if Vitamin K presents a cancer risk, although research has pretty much revealed that vitamin K administration is more than likely benign. (Passmore, et al , 1998. ) As I began to allow myself to search the medical literature, I realized I needed to rethink vitamin K issues and had to realign myself with current literature.
I would like to quote M. Andrew from the February 1997 Perinatology Seminars:
"Clinically, the hemostatic system is effective and healthy infants do not suffer from spontaneous hemorrhagic complications." (Andrew. 1997). Vitamin K is essential so that the liver can manufacture prothrombin and factors II, VII, IX, X in the clotting cascade. While the newborn infant has a deficit in these factors as long as his vitamin K stores are low, he also has increased factors V, VIII, and XIII surpassing those of the adult and thus providing the infant with an inborn protective mechanism. However, Andrew also states that infants are more vulnerable than adults to bleeding disorders. Andrew states that the most common causes of bleeding in newborns is vitamin K deficiency, DIC, and liver disease.
It is fact that newborn babies are born without sufficient vitamin K stores. For most babies this noted deficiency is not enough to cause hemorrhagic disorders in the newborn . However the medical literature is replete with research, and various case studies of breast fed infants developing vitamin K deficiency bleeding (VKDB). VKDB can cause serious internal and intracranial bleeding leading to death. In addition, case studies revealed that the infants who died from late onset vitamin K deficiency bleeding had received the initial one milligram dose of vitamin K injection at birth. One injection was not always protective. (Solves, et al. 1997., Rutty, Smith and Malia, 1999., Soylu, et al. 1997.). VKDB can occur within days to up to two months after delivery. Bacterial synthesis of vitamin K appears to be a deficient source for providing satisfactory levels of vitamin K in the newborn infant. Antibiotic administration has been documented to further interfere with vitamin K synthesis in the human intestinal tract. (Huigol, Markus, & Vakil, 1997.) This is significant given the reliance of the medical community on antibiotics. Colostrum and Breast milk contain very low levels of vitamin K, thus placing breast fed infants at higher risk than formula fed infants. (Sweet, 1997., Creasy and Resnik, 1989.) However, dietary sources can prevent vitamin K deficiency disease. One study revealed that Vitamin K plasma levels in the newborn were elevated during maternal supplementation of vitamin K up to 5 milligrams per day during first 12 weeks post delivery. (Greer et al, 1997). While it was generally accepted that IM vitamin K regimens were effective, a single dose of oral vitamin K at birth is not as effective as a single IM dose of vitamin K at preventing the development of late onset VKDB. New protocols are being considered that include three 2 milligram oral doses of micellular vitamin K preparations, at birth, at 8 days and at 30 days. Infants with this particular oral dosing had vitamin K plasma levels comparable to infants receiving an injection of vitamin K with the same sequential pattern. (Greer et al 1997, Schubiger, Gruter, Shearer, 1997.). Large multinational comparisons where failure rates per 100,000 infants revealed that of the various vitamin K protocols, even three routine oral doses of vitamin K were not as effective as intramuscular administration unless the breast fed infant was given an additional daily dose of 25 micrograms of vitamin K. (Cornielsen et al. 1997).
Symptoms of vitamin K deficiency include: Breast feeding, melena (Melena is black tarry stools that may be difficult to differentiate from meconium, but can be tested by placing the stool in water to see if the water turns pink. Meconium will not cause the water to turn pink.), cephalohematoma, vomiting of blood, prolonged jaundice, failure to thrive and warning bleeds such as bleeding from the umbilical site, nasal and oral bleeding, and prolonged bleeding at puncture sites.
Diagnoses of vitamin K deficiency is made by drawing a Prothrombin time (PT), fibrinogen, and platelet count. A prolonged PT together with normal fibrinogen and platelet levels is indicative of vitamin K deficiency. Laboratory values of plasma or urinary vitamin K levels can be drawn in addition to PT and fibrinogen studies. Administration of 1.0 mg of vitamin K should produce a correction of the prolonged PT, and bleeding. Vitamin K is rapidly absorbed and begins to work within 30 minutes of administration. Vitamin K can be given at any time after birth, especially if prolonged or abnormal bleeding is noted in the newborn. In addition, the newborn may appear quite healthy for several days or weeks, and the only sign will be what the practitioner may consider as prolonged or inconsequential bleeding around the umbilical stump. Note: Newborns do not bleed easily!!!
When discussing vitamin K issues with your clients your teaching tools need to be clear. Your clients need to understand why it is suggested their baby receive vitamin K, and they must understand that one injection is not necessarily adequate to prevent a later onset of this disorder in exclusively breast fed infants. Your clients must be told signs and symptoms of VKDB that they might notice during the course of normal care taking. VKDB can be fatal, or produce developmental and cognitive delays in the infant. It's rarity may not allow the practitioner ample experience to recognize it. In addition, a good teaching tool would include potential concerns for infants receiving vitamin K injections. Davis's Drug Guide for Nurses states the general side effects of phytonadione ( vitamin K1) one milligram include jaundice, hemolytic anemia, flushing, rash, urticaria, or a mild local reaction at the injection site. In addition any foreign entity given by injection can cause an anaphylactic reaction. While this is extremely rare, if that were to happen in the home, that would be a devastating event. One half to one milligram of vitamin K1 is the standard intramuscular dosage for a newborn, whereas 2 mg is the standard oral dosage. Phytonadione is not absorbed from the gastro-intestinal tract unless there are some bile salts present.
In addition to a clear, informative written teaching tool, I suggest having your parents sign that they desire vitamin K, or that they decline vitamin K irregardless of how the medication is provided (by you or by the parent). Prior to Amanda's birth, if the parents did not provide me with the medication then I felt it was safe to assume they chose not to give it. However, if a parent is not truly informed, or their practitioner refuses on the grounds that they are "aiding and abetting home birth", then that may place the midwife in legal limbo for not providing a standard routine medication, not to mention the heart ache of having a baby die or become developmentally disabled over a disease that can be prevented nutritionally.
I am not a licensed lawyer but what I am about to assert appears clear. Should a baby suffer the consequences of a medical practitioners neglect, whether due to ignorance or a personal bias regarding the safety of home delivery, given the laws of the land, where only medical doctors may prescribe medications, then the jury is left with one fact; a medical doctor was the only person licensed to prescribe medications for your client. If he or she refused to honor your clients rights as parents, and did not provide a standard medical treatment when so requested, then if you have educated your client, and done your best to present the facts, then it ultimately falls on the shoulders of the physician. In addition, if your state does not provide a legal clause for you to furnish newborn medications, (Texas does provide that for documented midwives), and you do so without a physicians order, you are breaking the law. It is called "practicing medicine without a license".
I propose that a registry of babies not given vitamin K prophylaxsis be started through Mana. With a registry, midwives can document statistics of health and well being. Babies who have not received vitamin K prophylaxis are now a rarity. Home born babies are the control population if we are to get to the truth regarding cancer epidemiology and vitamin K administration.
Bibliography
Andrew, M., (1997). The relevance of developmental hemostatsis
to hemorrhagic disorders of newborns.
Seminars In Perinatology. 21:1 pp.70-85.
Booth, S., & Suttie, J., (1998). Dietary intake and adequacy of vitamin K. Journal of Nutrition. 128:5.
p.p. 785-788.
Cornelissen, M., Von Kries, R., Loughnan, P., & Schubiger, G., (1997). Prevention of vitamin K
deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. European Journal
of Pediatrics. 156:2 p.p. 126-130.
Creasy, R., & Resnik, R., (1989). Maternal-Fetal Medicine: Principals & Practice. Saunders:
Philadelphia.
Deglin, J., & Vallerand, A., (1999). Davis's Drug Guide for Nurses. 6th Ed. FA Davis :Philadelphia.
Golding,J., Emmett, P., & Rogers, I. (1997). Does breast feeding have any impact on non-infectuous,
non- allergic disorders? Early Human Development. Supplement s131-42.
Greer, F., Marshall, S., foley,A., & Suttie, J. (1997). Improving vitamin K status of breast feeding
infants with maternal vitamin K supplenets. Pediatrics. 99:1 pp. 88-92.
Greer, F., Marshall, S., Severson,R., Smith,D., Shearer, M., Pace, D., & joubert, P. (1998).
A new mixed micellular preparation for oral vitamin K prophylaxis: randomised controlled
comparison with an imtramuscular formulation in breast fed infants. Archives of the Disabled Child.
79:4 pp. 300-305.
Huilgol, V., Markus,S., &Vakil, N. (1997). Antibiotic induced iatrogenic hemobilia. American Journal
of Gastroenterology. 92:4. Pp.706-707.
Passmore, S., Draper,G., Brownbill,P., & Krill, M. (1998). Ecological studies of the relation between
hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer.
British Medical Journal. 316:7126 pp.184-189.
Passmore, S., Draper,G., Brownbill,P., & Krill, M. (1998). Case control studies of relation between
childhood cancer & neonatal vitamin K administration. British Medical Journal. 316:7126
pp.178-184.
Rutty, G., Smith,C., & malia,R., (1999). Late form hemorrhagic disease of the newborn; a
fatal case report with illustration of investigations that may assist in avoiding the mistaken diagnosis of
child abuse. American Journal of Forensic Medical Pathology. 20:1 pp. 48-51.
Solves,P., Altes,A., ginovart.G., Demestre, J., & fontcuberta, J. (1997). Late hemorrhagic
disease of the newborn as a cause of intracerebral bleeding. Annals of hematology. 75:1-2 pp. 65-66.
Soylu, H., Aslan,Y., Sari, A., & Erduran, E. (1997). Intracerebral hemorrhagic: a rare
late manifestationof vitamin K deficiency in a breast fed infant. A case report. Turkish Journal
of Pediatrics. 39:2 pp. 265-269.
Sweet, B., Ed. (1997). Maye's Midwifery: A Textbook for Midwives. Balliere Tindall: Philadelphia.
Zipursky, A. (1999). Prevention of vitamin K deficiency in newborns. British Journal of of
Haematology.
104:3 pp. 430-437.
|